Kevin RobertsSenior Director of Research at Sorriso PharmaceuticalsSpeaker
Profile
Kevin Roberts is the Senior Director of Research for Sorriso Pharmaceuticals, located at the Magnify Incubator, UCLA. He has worked for over a decade to establish a pipeline of protease resistant disease-modifying single domain antibodies. Prior to joining Sorriso, Kevin was Director of Research at VHsquared Ltd., a biopharmaceutical company located in Cambridge, UK. During this time, he also held positions as a visiting researcher at the Wellcome Sanger Institute and the Jeffrey Cheah Biomedical Centre, Cambridge UK. Kevin holds a Ph.D. in Molecular Microbiology from the University of Cambridge.
Agenda Sessions
SOR102 is a Novel, Orally-Administered Anti-TNF/IL-23 Domain Antibody Therapy that Drives Clinical and Pharmacodynamic Responses in the Colonic Tissue of Ulcerative Colitis Patients
, 11:30amView Session